Chikungunya virus (CHIKV) outbreaks have affected the global population and demand effective antiviral strategies. Exploring the molecular mechanisms associated with its pathogenesis through modulation of host response is essential for the development of efficient antiviral interventions. Although CHIKV-encoded kinases are not perceived, the phosphorylation of CHIKV proteins in hosts is reported. Hence, elucidating the signaling cross-talks between host kinases and viral proteins provides opportunities for targeted therapeutic strategies.
Methods:
Toward this, we predicted the phosphosites in CHIKV proteins and their potential host kinases using multiple prediction tools, followed by a human kinase substrate phosphomotif pattern analysis to identify putative kinase interactions. The phosphoproteome of CHIKV and CHIKV-infected host cells and further the host-viral interactome were analyzed in conjunction with kinase inhibition assays to identify host kinases associated with their infection. Subsequently, in silico protein-protein docking was performed between the selected kinases and viral proteins to identify potential interactions.
Results and Conclusion:
In silico analysis revealed Mitogen-activated protein kinase 1 (MAPK1), Protein kinase C alpha (PRKCA), and Eukaryotic elongation factor 2 kinase (EEF2K) as major host kinases of specific phosphosites in CHIKV proteins. Putative kinases were also predicted for the reported phosphorylation sites in the CHIKV phosphoproteome. This study reveals that host kinases may phosphorylate substrates critical to CHIKV persistence and pathogenesis and emphasizes the potential of targeting host kinases as an adjunct to antiviral strategies. Our approach demonstrates the utility of kinase substrate specificity modeling to identify host kinases that can interact with viral proteins for their selection as drug-repurposable targets, particularly for variants and viruses without efficient/approved vaccines.
AbdelnabiR, AmrunSN, NgLFP, et al.Protein kinases C as potential host targets for the inhibition of chikungunya virus replication. Antiviral Res, 2017; 139:79–87; doi: 10.1016/j.antiviral.2016.12.020
2.
AholaT, MeritsA. Functions of chikungunya virus nonstructural proteins. In: Chikungunya Virus. Springer International Publishing: Cham; 2016; pp. 75–98; doi: 10.1007/978-3-319-42958-8_6
3.
BattistiV, UrbanE, LangerT. Antivirals against the chikungunya virus. Viruses, 2021; 13(7):1307; doi: 10.3390/v13071307
4.
BhutkarM, SahaA, TomarS. Viral Methyltransferase inhibitors: Berbamine, Venetoclax, and Ponatinib as Efficacious Antivirals against Chikungunya Virus. Arch Biochem Biophys, 2024; 759:110111; doi: 10.1016/j.abb.2024.110111
5.
BlomN, GammeltoftS, BrunakS. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol, 1999; 294(5):1351–1362; doi: 10.1006/jmbi.1999.3310
6.
BouraïM, Lucas-HouraniM, GadHH, et al.Mapping of chikungunya virus interactions with host proteins identified NsP2 as a highly connected viral component. J Virol, 2012; 86(6):3121–3134; doi: 10.1128/JVI.06390-11
7.
BurleySK, BhikadiyaC, BiC, et al.RCSB Protein Data Bank: Powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res, 2021; 49(D1):D437–D451; doi: 10.1093/nar/gkaa1038
8.
ChakravartyA, YangPL. Targeted protein degradation as an antiviral approach. Antiviral Res, 2023; 210:105480; doi: 10.1016/j.antiviral.2022.105480
9.
CharrelRN, de LamballerieX, RaoultD. Chikungunya outbreaks–The globalization of vectorborne diseases. N Engl J Med, 2007; 356(8):769–771; doi: 10.1056/NEJMp078013
10.
ChenC-W, HuangL-Y, LiaoC-F, et al.GasPhos: Protein phosphorylation site prediction using a new feature selection approach with a GA-aided ant colony system. Int J Mol Sci, 2020; 21(21):7891; doi: 10.3390/ijms21217891
11.
ChmielewskiD, SuG-C, KaelberJT, et al.Cryogenic electron microscopy and tomography reveal imperfect icosahedral symmetry in alphaviruses. PNAS Nexus, 2024; 3(3):pgae102; doi: 10.1093/pnasnexus/pgae102
12.
ConstantLEC, RajsfusBF, CarneiroPH, et al.Overview on chikungunya virus infection: From epidemiology to state-of-the-art experimental models. Front Microbiol, 2021; 12:744164; doi: 10.3389/fmicb.2021.744164
13.
CunhaRVd, TrintaKS. Chikungunya virus: Clinical aspects and treatment—a review. Mem Inst Oswaldo Cruz, 2017; 112(8):523–531; doi: 10.1590/0074-02760170044
14.
de Lima CavalcantiTYV, PereiraMR, de PaulaSO, et al.A review on chikungunya virus epidemiology, pathogenesis and current vaccine development. Viruses, 2022; 14(5):969; doi: 10.3390/v14050969
15.
DominguezF, ShiliaevN, LukashT, et al.NAP1L1 and NAP1L4 binding to hypervariable domain of chikungunya virus NsP3 protein is bivalent and requires phosphorylation. J Virol, 2021; 95(16):e0083621; doi: 10.1128/JVI.00836-21
16.
FreppelW, SilvaLA, StaplefordKA, et al.Pathogenicity and virulence of chikungunya virus. Virulence, 2024; 15(1):2396484; doi: 10.1080/21505594.2024.2396484
17.
FrosJJ, LiuWJ, ProwNA, et al.Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. J Virol, 2010; 84(20):10877–10887; doi: 10.1128/JVI.00949-10
18.
GaoY, GoonawardaneN, WardJ, et al.Multiple roles of the non-structural protein 3 (NsP3) alphavirus unique domain (AUD) during chikungunya virus genome replication and transcription. PLoS Pathog, 2019; 15(1):e1007239; doi: 10.1371/journal.ppat.1007239
GopalakrishnanAP, ShivamurthyPB, AhmedM, et al.Positional distribution and conservation of major phosphorylated sites in the human kinome. Front Mol Biosci, 2025; 12:1557835; doi: 10.3389/fmolb.2025.1557835
21.
HoarauJ-J, Jaffar BandjeeM-C, Krejbich TrototP, et al.Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol, 2010; 184(10):5914–5927; doi: 10.4049/jimmunol.0900255
22.
HornbeckPV, KornhauserJM, LathamV, et al.15 years of PhosphoSitePlus®: Integrating post-translationally modified sites, disease variants and isoforms. Nucleic Acids Res, 2019; 47(D1):D433–D441; doi: 10.1093/nar/gky1159
23.
JohnsonJL, YaronTM, HuntsmanEM, et al.An Atlas of substrate specificities for the human serine/threonine kinome. Nature, 2023; 613(7945):759–766; doi: 10.1038/s41586-022-05575-3
24.
JonesPH, MaricM, MadisonMN, et al.BST-2/Tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV Non-structural protein 1 (NsP1). Virology, 2013; 438(1):37–49; doi: 10.1016/j.virol.2013.01.010
25.
KhanAH, MoritaK, ParquetMDC, et al.Complete Nucleotide sequence of chikungunya virus and evidence for an internal polyadenylation site. J Gen Virol, 2002; 83(Pt 12):3075–3084; doi: 10.1099/0022-1317-83-12-3075
LiK-B. ClustalW-MPI: ClustalW analysis using distributed and parallel computing. Bioinformatics, 2003; 19(12):1585–1586; doi: 10.1093/bioinformatics/btg192
28.
MahinA, Chikmagalur RavindraS, RameshP, et al.Unveiling actin cytoskeleton role in mediating chikungunya-associated arthritis: An integrative Proteome-Metabolome study. Vector Borne Zoonotic Dis, 2024; 24(11):753–762; doi: 10.1089/vbz.2024.0018
29.
MaletH, CoutardB, JamalS, et al.The crystal structures of chikungunya and venezuelan equine encephalitis virus NsP3 macro domains define a conserved adenosine binding pocket. J Virol, 2009; 83(13):6534–6545; doi: 10.1128/JVI.00189-09
30.
MathurK, AnandA, DubeySK, et al.Analysis of chikungunya virus proteins reveals that non-structural proteins NsP2 and NsP3 exhibit RNA interference (RNAi) suppressor activity. Sci Rep, 2016; 6:38065; doi: 10.1038/srep38065
31.
MondolSM, HasibM, LimonMBH, et al.Insights into Omicron’s low fusogenicity through in silico molecular studies on Spike-Furin interactions. Bioinform Biol Insights, 2023; 17:11779322231189371; doi: 10.1177/11779322231189371
32.
MontgomerySA, BerglundP, BeardCW, et al.Ribosomal protein S6 associates with alphavirus nonstructural protein 2 and mediates expression from alphavirus messages. J Virol, 2006; 80(15):7729–7739; doi: 10.1128/JVI.00425-06
33.
NavhayaLT, MatsebatlelaTM, MonamaMZ, et al.In silico discovery and evaluation of inhibitors of the SARS-CoV-2 Spike Protein-HSPA8 complex towards developing COVID-19 therapeutic drugs. Viruses, 2024; 16(11):1726; doi: 10.3390/v16111726
34.
PiserchioA, LongKJ, BrowningLS, et al.ADP enhances the allosteric activation of Eukaryotic elongation factor 2 kinase by calmodulin. Proc Natl Acad Sci USA, 2023; 120(17); doi: 10.1073/pnas.2300902120
35.
PollBG, LeoKT, DeshpandeV, et al.A resource database for protein kinase substrate sequence-preference motifs based on large-scale mass spectrometry data. Cell Commun Signal, 2024; 22(1):137; doi: 10.1186/s12964-023-01436-2
36.
RanaJ, GulatiS, RajasekharanS, et al.Identification of Potential Molecular Associations between chikungunya virus non-structural protein 2 and human host proteins. Acta Virol, 2017; 61(1):39–47; doi: 10.4149/av_2017_01_39
37.
ShajiV, RafiA, AhmedM, et al.Analysis of phosphomotifs coupled to phosphoproteome and interactome unveils potential human kinase substrate proteins in SARS-CoV-2. Front Cell Infect Microbiol, 2025; 15:1554760; doi: 10.3389/fcimb.2025.1554760
SolignatM, GayB, HiggsS, et al.Replication cycle of chikungunya: A re-emerging arbovirus. Virology, 2009; 393(2):183–197; doi: 10.1016/j.virol.2009.07.024
40.
St DenisJD, ChessariG, CleasbyA, et al.X-Ray screening of an electrophilic fragment library and application toward the development of a novel ERK 1/2 covalent inhibitor. J Med Chem, 2022; 65(18):12319–12333; doi: 10.1021/acs.jmedchem.2c01044
41.
SugiyamaN, ImamuraH, IshihamaY. Large-Scale discovery of substrates of the human kinome. Sci Rep, 2019; 9(1):10503; doi: 10.1038/s41598-019-46385-4
42.
TepporM, ŽusinaiteE, MeritsA. Phosphorylation sites in the hypervariable domain in chikungunya virus NsP3 are crucial for viral replication. J Virol, 2021; 95(9):e02276–e02220; doi: 10.1128/JVI.02276-20
43.
ThannickalSA, BattiniL, SpectorSN, et al.Changes in the chikungunya virus E1 Glycoprotein domain II and Hinge influence E2 conformation, infectivity, and virus-receptor interactions. J Virol, 2024; 98(7):e0067924; doi: 10.1128/jvi.00679-24
44.
TreffersEE, TasA, ScholteFEM, et al.The alphavirus nonstructural protein 2 NTPase induces a host translational shut-off through phosphorylation of EEF2 via CAMP-PKA-EEF2K signaling. PLoS Pathog, 2023; 19(2):e1011179; doi: 10.1371/journal.ppat.1011179
45.
UllahK, ChenS, LuJ, et al.Correction: The E3 ubiquitin ligase STUB1 attenuates cell senescence by promoting the ubiquitination and degradation of the core circadian regulator BMAL1. J Biol Chem, 2020; 295(32):11378; doi: 10.1074/jbc.AAC120.015160
46.
UniProt Consortium. UniProt: The universal protein knowledgebase in 2023. Nucleic Acids Res, 2023; 51(D1):D523–D531; doi: 10.1093/nar/gkac1052
VisserM, PapillonJPN, LuzzioM, et al.Discovery of darovasertib (NVP-LXS196), a Pan-PKC inhibitor for the treatment of metastatic uveal melanoma. J Med Chem, 2024; 67(2):1447–1459; doi: 10.1021/acs.jmedchem.3c02002
49.
WangD, ZengS, XuC, et al.MusiteDeep: A deep-learning framework for general and kinase-specific phosphorylation site prediction. Bioinformatics, 2017; 33(24):3909–3916; doi: 10.1093/bioinformatics/btx496
50.
WangS, MahalingamS, MeritsA. Alphavirus NsP2: A multifunctional regulator of viral replication and promising target for anti-alphavirus therapies. Rev Med Virol, 2025; 35(2):e70030; doi: 10.1002/rmv.70030
51.
WeberC, BerberichE, von RheinC, et al.Identification of functional determinants in the chikungunya virus E2 protein. PLoS Negl Trop Dis, 2017; 11(1):e0005318; doi: 10.1371/journal.pntd.0005318
52.
Yaron-BarirTM, JoughinBA, HuntsmanEM, et al.The intrinsic substrate specificity of the human tyrosine kinome. Nature, 2024; 629(8014):1174–1181; doi: 10.1038/s41586-024-07407-y
53.
YinH, YinP, ZhaoH, et al.Intraviral interactome of chikungunya virus reveals the homo-oligomerization and palmitoylation of structural protein TF. Biochem Biophys Res Commun, 2019; 513(4):919–924; doi: 10.1016/j.bbrc.2019.04.098
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
